Insider · CIK 0001340881

Drapkin Kimberlee C

Reports to the SEC for 6 companies · SOLANA BEACH, CA

sec.gov

Transactions

Companies

Filings

CIK

0001340881

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-15	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+22.1K sh	—	—	22,100
2026-06-05	CLYMClimb Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2026-06-03	ABOSAcumen Pharmaceuticals, Inc.A Award	Director	AAward	+35.5K sh	—	—	48,300
2026-06-03	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+53.3K sh	—	—	53,250
2025-06-30	KINETA, INC./DEStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2025-06-30	KINETA, INC./DED Disposition to Issuer	Director	DDisposition to Issuer	−13.8K sh	—	—	0
2025-06-25	KINETA, INC./DEA Award	Director	AAward	+6,000 sh	—	—	13,794
2025-06-23	KINETA, INC./DEStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.5K sh	—	—	0
2025-06-23	KINETA, INC./DEM Exercise/Conversion	Director	MExercise/Conversion	+12.5K sh	$0.61	+$7,637.5	12,500
2025-06-23	KINETA, INC./DEF Tax Payment	Director	FTax Payment	−4,706 sh	$0.26	−$1,223.56	7,794
2025-06-11	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,500
2025-06-04	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19.5K sh	—	—	19,500
2025-06-04	CLYMClimb Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2025-06-04	ABOSAcumen Pharmaceuticals, Inc.A Award	Director	AAward	+12.8K sh	—	—	12,800
2025-03-28	CLYMClimb Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+80K sh	—	—	80,000
2024-09-04	KINETA, INC./DEStock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2024-06-10	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2024-03-21	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+27K sh	—	—	27,000
2023-07-28	LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-07-01	KINETA, INC./DEStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2023-06-06	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-05-03	Jounce Therapeutics, Inc.U Disposition from Tender	President, CFO and Treasurer	UDisposition from Tender	−25.8K sh	—	—	40,267
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	President, CFO and Treasurer	DDisposition to Issuer	−77.2K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	President, CFO and Treasurer	DDisposition to Issuer	−8,130 sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.U Disposition from Tender	President, CFO and Treasurer	UDisposition from Tender	−40.3K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	President, CFO and Treasurer	DDisposition to Issuer	−206K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	President, CFO and Treasurer	DDisposition to Issuer	−55K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	President, CFO and Treasurer	DDisposition to Issuer	−44.5K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	President, CFO and Treasurer	DDisposition to Issuer	−53.4K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	President, CFO and Treasurer	DDisposition to Issuer	−44.5K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	President, CFO and Treasurer	DDisposition to Issuer	−97.5K sh	—	—	0
2023-01-10	Jounce Therapeutics, Inc.S Sale	President, CFO and Treasurer	SSale	−7,781 sh	$1.12	−$8,714.72	66,018
2023-01-09	Jounce Therapeutics, Inc.S Sale	President, CFO and Treasurer	SSale	−6,315 sh	$1.10	−$6,946.5	73,799
2022-06-15	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-04-01	ABOSAcumen Pharmaceuticals, Inc. · Stock Option Grant (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2022-02-01	Jounce Therapeutics, Inc.A Award	President, CFO and Treasurer	AAward	+27.5K sh	—	—	80,114
2022-02-01	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	President, CFO and Treasurer	AAward	+55K sh	—	—	55,000
2022-01-10	Jounce Therapeutics, Inc.S Sale	President, CFO and Treasurer	SSale	−8,222 sh	$6.65	−$54.7K	52,614
2022-01-07	Jounce Therapeutics, Inc.S Sale	President, CFO and Treasurer	SSale	−4,595 sh	$7.30	−$33.5K	60,836
2021-06-02	KINETA, INC./DEStock Option (Right to Buy)A Award	Director	AAward	+14.8K sh	—	—	14,800
2021-02-01	Jounce Therapeutics, Inc.A Award	President, CFO and Treasurer	AAward	+22.3K sh	—	—	65,431
2021-02-01	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	President, CFO and Treasurer	AAward	+44.5K sh	—	—	44,500
2021-01-21	Jounce Therapeutics, Inc.M Exercise/Conversion	President, CFO and Treasurer	MExercise/Conversion	+3,799 sh	$2.36	+$8,965.64	46,980
2021-01-21	Jounce Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	President, CFO and Treasurer	MExercise/Conversion	−3,799 sh	—	—	206,005
2021-01-21	Jounce Therapeutics, Inc.S Sale	President, CFO and Treasurer	SSale	−3,799 sh	$12.00	−$45.6K	43,181
2021-01-20	Jounce Therapeutics, Inc.M Exercise/Conversion	President, CFO and Treasurer	MExercise/Conversion	+3,016 sh	$0.48	+$1,447.68	58,897
2021-01-20	Jounce Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	President, CFO and Treasurer	MExercise/Conversion	−3,710 sh	—	—	209,804
2021-01-20	Jounce Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	President, CFO and Treasurer	MExercise/Conversion	−6,775 sh	—	—	0
2021-01-20	Jounce Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	President, CFO and Treasurer	MExercise/Conversion	−3,016 sh	—	—	0
2021-01-20	Jounce Therapeutics, Inc.S Sale	President, CFO and Treasurer	SSale	−10K sh	$10.03	−$100K	43,181

Recent filings

Accepted (ET)
Jun 154
Drapkin Kimberlee C0001340881-26-000001
SEC(opens sec.gov)
Jun 84
Drapkin Kimberlee C0001193125-26-262290
SEC(opens sec.gov)
Jun 54
Drapkin Kimberlee C0001628280-26-041276
SEC(opens sec.gov)
Jul 24
Drapkin Kimberlee C0000950170-25-093062
SEC(opens sec.gov)
Jun 254
Drapkin Kimberlee C0000950170-25-090145
SEC(opens sec.gov)
Jun 114
Drapkin Kimberlee C0001815776-25-000047
SEC(opens sec.gov)
Jun 54
Drapkin Kimberlee C0001576885-25-000081
SEC(opens sec.gov)
Jun 54
Drapkin Kimberlee C0000950170-25-082335
SEC(opens sec.gov)
Apr 14
Drapkin Kimberlee C0000950170-25-048555
SEC(opens sec.gov)
Sep 54
Drapkin Kimberlee C0000950170-24-104013
SEC(opens sec.gov)
Jun 104
Drapkin Kimberlee C0001576885-24-000075
SEC(opens sec.gov)
Mar 254
Drapkin Kimberlee C0001815776-24-000026
SEC(opens sec.gov)
Aug 14
Drapkin Kimberlee C0001209191-23-044075
SEC(opens sec.gov)
Jul 54
Drapkin Kimberlee C0001209191-23-041031
SEC(opens sec.gov)

Companies

Address

C/O LENZ THERAPEUTICS, INC. 201 LOMAS SANTA FE DRIVE, SUITE 300

SOLANA BEACH, CA, 92075